Business

gematik extends DocMorris CardLink approval until January 2027

gematik extends DocMorris CardLink approval until January 2027

Docmorris LtdJuly 15, 20254
gematik extends DocMorris CardLink approval until January 2027

About this update from Docmorris Ltd

DocMorris AG / Key word(s): Miscellaneousgematik extends DocMorris CardLink approval until January 2027 15.07.2025 / 07:00 CET/CESTFrauenfeld, 15 July 2025Press releasegematik extends DocMorris CardLink approval until January 2027Approval extension ensures seamless transition to successor technology PoPPgematik will also enable contactless use of the eGK without a PIN in the context of PoPPgematik has extended the product approval for DocMorris' CardLink solution until the end of January 2027. Patients can therefore continue to redeem their e-prescriptions with their electronic health card (eGK) and the DocMorris app, while at the same time a seamless transition to the successor technology PoPP (Proof of Patient Presence) is ensured.“We welcome the fact that gematik worked with all parties involved at an early stage to find a transitional arrangement for fully digital e-prescription redemption until the nationwide introduction of PoPP. By enabling the contactless use of the eGK without a PIN, even in the context of PoPP, our customers can continue to rely on learned redemption methods for their e-prescriptions in the future,” says Walter Hess, CEO DocMorris.Investors and analyst contactDr. Daniel Grigat, Head of Investor Relations & SustainabilityEmail: [email protected], phone: +41 52 560 58 10Media contactTorben Bonnke, Director CommunicationsEmail: [email protected], phone: +49 171 864 888 1Agenda19 August 20252025 Half-year results (conference call/webcast)16 October 2025Q3/2025 Trading update20 January 2026Sales 202519 March 20262025 Full-year results and outlook 2026 (conference call/webcast)16 April 2026Q1/2026 Trading update12 May 2026Annual General Meeting, Zurich19 August 20262026 Half-year results (conference call/webcast)15 October 2026Q3/2026 Trading update DocMorrisThe Swiss-based DocMorris AG is a leading company in the fields of online pharmacy, marketplace and professional healthcare with strong brands in Germany and other European countries. Deliveries are mainly from the highly automated logistics centre in Heerlen, the Netherlands, with a capacity of over 27 million parcels per year. In Spain and France, the company operates the leading marketplace for health and personal care products in Southern Europe. With its business model, DocMorris offers its patients, customers and partners a broad range of products and services. In doing so,...

View stock analysis, news, and events for Docmorris Ltd